Brilliant Violet 421TM anti-human CD27 [M-T271] and 1 more item

The University of Virginia awarded a contract to BioLegend Inc. on July 24, 2026, for the procurement of specialized laboratory reagents in Virginia. The contract, identified as A207_PO-0461738, totals $378.00 and encompasses two flow cytometry antibody products: Brilliant Violet 421 anti-human CD27 [M-T271] at a unit price of $285.75 and FITC (fluorescein isothiocyanate) anti-human CD20 [2H7] at a unit price of $92.40. Both items, with a quantity of one unit each, are designated for delivery to Melissa A Marshall.

The contract represents a straightforward procurement of immunological research reagents by the University of Virginia through its contracting organization. These monoclonal antibodies are standard tools utilized in flow cytometry applications for cell identification and analysis in immunological research. With a cumulative contract value of $378.00 and performance taking place in Virginia, this award reflects routine procurement activities supporting the university's research operations. No period of performance duration is specified in the available documentation.